Risk stratification for distant metastasis after postoperative (chemo)radiotherapy in head and neck squamous cell carcinoma.
With the emergence of immune checkpoint inhibitors for resectable locally advanced head and neck squamous cell carcinoma (HNSCC), identifying patients most likely to experience distant relapse after standard postoperative treatment has become increasingly important. The purpose of this study was to evaluate recurrence...